Justin’s Winery of the Year honor beyond ‘wildest dreams’
I asked Justin Baldwin what message he would deliver later this month at an awards dinner in New York honoring Justin Vineyards & Winery as Wine Enthusiast magazine’s American Winery of the Year. “Wow” was the first word that came to mind. He recalled that when he started the operation 35 years ago, it was Read More →
Compass expands online luxury real estate platform to SB, Montecito
A new online platform is poised to shake up the region’s luxury residential real estate market. New York-based Compass uses in-house software that aims to cut down on brokers’ administrative work and streamline listing updates. The startup recently announced that it is expanding into the Santa Barbara and Montecito markets. The South Coast is the Read More →
Baxalta’s fast exit shows need for corporate tax fix
Baxalta, we hardly knew ya. Just six months after it was spun off from parent Baxter International, Baxalta, a major employer in East Ventura County, is to be sold to Shire, an Irish firm. The future of some 1,200 employees in Westlake Village and the Newbury Park area of Thousand Oaks is now uncertain, as Read More →
Forced arbitration violates your rights
By Lisa Spiwak Arbitration has become very popular as an alternative dispute resolution to the traditional court system. Arbitration’s popularity stems from the fact that it is a way to resolve legal disputes outside of the courts in a faster, cheaper and more flexible manner. Arbitration awards are completely binding on the parties and those Read More →
Internet of Things lights up CES
By David Newton LAS VEGAS — Another year at the Consumer Electronics Show and more records fell. Attendance topped 173,000 — including 50,000 from outside the U.S. — with 3,800 exhibitors covering 2.5 million square feet. But this year did not have any truly impressive, jaw-dropping product-tech debuts and felt very much like the last Read More →
Amgen suffers setback as patent office refuses to review competitor’s drug
The U.S. Patent and Trademark Office handed Amgen a potential setback Jan. 14 when it declined to review two patent expiration dates on a competitor’s drug. In June, Thousand Oaks-based biotech giant Amgen asked the agency to review two formulation patents for Humira, made by Chicago-based competitor AbbVie, arguing that the patents should not have Read More →
Limoneira misses Wall Street expectations for fourth quarter
Santa Paula-based Limoneira Co. reported fiscal fourth-quarter net income of $654,000 on Jan. 11 after reporting a loss in the same period a year earlier. The company said it had profit of 4 cents per share. Losses, adjusted for non-recurring gains, came to 23 cents per share. The results did not meet Wall Street expectations. Read More →
